This globally operating pharmaceutical company focuses on developing and manufacturing a broad range of affordable medications. They specialize in both prescription and over-the-counter drugs, including oncology treatments, antibacterials, injectables (both specialty and large volume), ophthalmic products, dermatological preparations, and veterinary pharmaceuticals. Their product portfolio also includes unique niche drugs and orphan products, showcasing their commitment to addressing diverse medical needs. The company boasts state-of-the-art manufacturing facilities located across several regions, adhering to strict quality standards recognized by international regulatory bodies like the WHO GMP, US FDA, and MCC. Their extensive global reach spans over 45 countries in Asia, Africa, Latin America, CIS, Europe, Australia, and the Pacific Ocean. The company's focus on research and development, coupled with its global manufacturing capabilities and commitment to quality, positions them as a key player in the international pharmaceutical market.

Established in 2004, this manufacturer specializes in injectable medicines, including a wide portfolio of generic and specialty products, notably contrast media injections. As a CTD dossier owner and manufacturer, it holds WHO-GMP and ISO 9001:2015 certifications, ensuring compliance with international quality standards. The manufacturer operates a state-of-the-art sterile manufacturing unit adhering to stringent GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed across various regions, including Africa, South Asia, and Southeast Asia. With a focus on research and development, the manufacturer is committed to delivering high-quality healthcare solutions.